Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/PEC.0000000000000648 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Retrospective Comparison of Early Versus Late Initiation of Long-Acting Insulin in Critically Ill Pediatric Patients in Diabetic Ketoacidosis.
J Pediatr Pharmacol Ther
December 2024
Department of Pharmacy, Stormont Vail Health, Topeka, KS.
Objective: Determine whether early administration (EA) of long-acting insulin in pediatric diabetic -ketoacidosis (DKA) reduces time to acidosis resolution while maintaining safety when compared with late administration (LA).
Methods: This retrospective review compared EA (within 4 hours) to LA (4 to 24 hours) of long-acting insulin in DKA management in the pediatric intensive care unit between 2015 and 2022. Admissions were excluded for patients ≥18 years of age, without type 1 diabetes, with insufficient laboratory data, or who did not receive insulin glargine within 24 hours of starting treatment.
Continuous glucose monitoring (Dexcom g6) in people with diabetes after kidney transplantation.
Ren Fail
December 2024
Department of Nephrology, Dialysis and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
Article Synopsis
- * Nine participants (mostly women with median age 57) were monitored over 30 days using the Dexcom G6 CGM system after kidney transplantation, revealing that time in the healthy glucose range was above 70%.
- * While the CGM use didn't change HbA1c levels or overall quality of life perception, it did enhance health quality perception for participants, indicating a potential benefit that warrants further research.
Long-term TNF-alpha therapy for preserving beta cell function in new onset type 1 diabetes: a case report.
Clin Diabetes Endocrinol
September 2024
Department of Diabetes, Queen Elizabeth Hospital, University Hospitals of Birmingham, Birmingham, UK.
Background: Type 1 diabetes mellitus (T1D) is an autoimmune disease caused by destruction of pancreatic islet beta-cells. There is significant residual beta-cell function, measured through circulating C-peptide, present at the time of T1D diagnosis but this subsequently decreases with time. Higher residual beta-cell function at diagnosis associates with better glycaemic control and less glucose variability, and later in the disease course with less hypoglycaemia, lower glucose variability and fewer microvascular complications.
View Article and Find Full Text PDFEvaluating the safety profile of semaglutide: an updated meta-analysis.
Curr Med Res Opin
September 2024
University of Arizona, Tucson, AZ, USA.
Background: Semaglutide is increasingly used in the management of type 2 diabetes mellitus and obesity. Ensuring the safety of this medication is crucial for its clinical use. This meta-analysis evaluates the safety profile of semaglutide across patient populations and treatment durations.
View Article and Find Full Text PDFRapid-Onset Obsessive-Compulsive Disorder With Hallucinations in a Post-seizure Four-Year-Old Male.
Cureus
June 2024
Pediatric Psychiatry, University of Illinois College of Medicine Peoria, Peoria, USA.
Rapid-onset obsessive-compulsive disorder (OCD) has been classically described in the context of infectious and autoimmune stressors, most famously PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections) and then PANS (pediatric autoimmune neuropsychiatric syndrome). PANS itself, however, specifically excludes neurological and medical disorders, including seizures, from the diagnostic criteria. Changes in affect, such as depression/anxiety and new-onset psychosis, have been previously described in the post-seizure period but often self-resolve.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!